Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 448,795,904
  • Shares Outstanding, K 2,632,543
  • Annual Sales, $ 82,059 M
  • Annual Income, $ 15,119 M
  • 60-Month Beta 0.70
  • Price/Sales 5.43
  • Price/Cash Flow 14.41
  • Price/Book 6.68
Trade JNJ with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 1.81
  • Number of Estimates 7
  • High Estimate 1.83
  • Low Estimate 1.76
  • Prior Year 1.88
  • Growth Rate Est. (year over year) -3.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
152.30 +10.23%
on 12/28/20
173.65 -3.32%
on 01/26/21
+15.41 (+10.11%)
since 12/24/20
3-Month
133.65 +25.61%
on 10/30/20
173.65 -3.32%
on 01/26/21
+24.73 (+17.28%)
since 10/27/20
52-Week
109.16 +53.79%
on 03/23/20
173.65 -3.32%
on 01/26/21
+19.13 (+12.86%)
since 01/27/20

Most Recent Stories

More News
EXPLAINER: Why it's hard to make vaccines and boost supplies

With demand for COVID-19 vaccines outpacing the world’s supplies, a frustrated public and policymakers want to know: How can we get more? A lot more. Right away.

PFE : 36.24 (-2.87%)
JNJ : 167.88 (-1.53%)
Asian shares drop after US stocks' worst day since October

TOKYO (AP) — Asian shares skidded on Thursday as a reality check set in about longtime economic damage from the coronavirus pandemic, giving Wall Street its worst day since October.

JNJ : 167.88 (-1.53%)
TSLA : 864.16 (-2.14%)
BA : 194.03 (-3.97%)
NFLX : 523.28 (-6.88%)
PFE : 36.24 (-2.87%)
JNJ Touches New Highs Post Solid Q4 Earnings: ETFs in Focus

The solid results coupled with upbeat vaccine data optimism pushed JNJ shares to all-time high.

JNJ : 167.88 (-1.53%)
PFE : 36.24 (-2.87%)
MRNA : 155.73 (+2.50%)
XLV : 114.34 (-3.04%)
VHT : 227.28 (-3.02%)
IYH : 249.26 (-3.08%)
IHE : 181.34 (-2.63%)
IEIH : 33.50 (-3.15%)
Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.

JNJ : 167.88 (-1.53%)
Company News for Jan 27, 2021

Companies In The News Are: JNJ, MMM, FCX, PII

JNJ : 167.88 (-1.53%)
MMM : 186.65 (+6.08%)
FCX : 25.79 (-4.52%)
PII : 117.37 (-5.10%)
Thinking about trading options or stock in Moderna, Walgreens Boots Alliance, Johnson & Johnson, Bed Bath & Beyond, or Exxon Mobil?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRNA, WBA, JNJ, BBBY, and XOM.

BBBY : 52.89 (+43.45%)
MRNA : 155.73 (+2.50%)
WBA : 51.18 (+4.05%)
JNJ : 167.88 (-1.53%)
XOM : 45.35 (-1.13%)
NASDAQ Winning Streak Ends as Stocks Slip Slightly

NASDAQ Winning Streak Ends as Stocks Slip Slightly

FNKO : 12.54 (+2.37%)
VET : 4.59 (-1.71%)
DNOW : 7.96 (-1.73%)
HIMX : 9.90 (+1.43%)
SAVA : 19.75 (+1.65%)
ETSY : 193.37 (-5.40%)
VCEL : 40.15 (-1.71%)
KMT : 39.27 (-3.73%)
STMP : 238.33 (-0.98%)
OSTK : 86.79 (+0.40%)
NTAP : 68.89 (+4.86%)
NEO : 53.53 (-2.53%)
VZ : 55.13 (-2.55%)
IIPR : 187.99 (-6.51%)
CRON : 10.34 (-0.39%)
HEXO : 6.48 (-2.11%)
APHA : 13.01 (+0.31%)
MSFT : 232.90 (+0.25%)
MMM : 186.65 (+6.08%)
JNJ : 167.88 (-1.53%)
GME : 347.51 (+134.84%)
AAPL : 142.06 (-0.77%)
FB : 272.14 (-3.51%)
TSLA : 864.16 (-2.14%)
Asian shares mixed following lackluster day on Wall Street

Asian stocks were mixed on Wednesday after a lackluster session on Wall Street.

TSLA : 864.16 (-2.14%)
AXP : 114.09 (-1.77%)
JNJ : 167.88 (-1.53%)
General Electric, Raytheon rise; Crane, Rockwell fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday:

JNJ : 167.88 (-1.53%)
CR : 75.76 (-2.02%)
ROK : 241.05 (-1.39%)
MTCH : 131.55 (-4.96%)
ALV : 88.72 (-2.84%)
J&J 4Q sales rise despite pandemic, but charges cut profits

A big jump in prescription drug sales boosted fourth-quarter revenue at Johnson & Johnson, despite the coronavirus pandemic cutting into sales of products from contact lenses to surgical equipment and...

PFE : 36.24 (-2.87%)
JNJ : 167.88 (-1.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

3rd Resistance Point 173.52
2nd Resistance Point 172.22
1st Resistance Point 170.05
Last Price 167.88
1st Support Level 166.58
2nd Support Level 165.28
3rd Support Level 163.11

See More

52-Week High 173.65
Last Price 167.88
Fibonacci 61.8% 149.01
Fibonacci 50% 141.40
Fibonacci 38.2% 133.80
52-Week Low 109.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar